Candel Therapeutics, Inc. (CADL) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $587.0K | +3568.8% |
| 2024 | $16.0K | -96.5% |
| 2023 | $457.0K | -64.8% |
| 2022 | $1.30M | -29.3% |
| 2021 | $1.83M | +24.3% |
| 2020 | $1.48M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $587.0K | +3568.8% |
| 2024 | $16.0K | -96.5% |
| 2023 | $457.0K | -64.8% |
| 2022 | $1.30M | -29.3% |
| 2021 | $1.83M | +24.3% |
| 2020 | $1.48M | — |